These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 10921001)
1. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features]. Jiang M; Shao Z; Wu J Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):181-4. PubMed ID: 10921001 [TBL] [Abstract][Full Text] [Related]
2. [Study on p53, mdm-2 and p21WAF1 protein expression in ER-positive and ER-negative human breast cancer cell lines and its relation to biological features]. Jiang M; Shao Z; Zhang Y Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):327-30. PubMed ID: 10374318 [TBL] [Abstract][Full Text] [Related]
3. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991 [TBL] [Abstract][Full Text] [Related]
4. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. Liu W; Zhang R Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438 [TBL] [Abstract][Full Text] [Related]
6. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043 [TBL] [Abstract][Full Text] [Related]
7. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression. Kralj M; Husnjak K; Körbler T; Pavelić J Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191 [TBL] [Abstract][Full Text] [Related]
8. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1. Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675 [TBL] [Abstract][Full Text] [Related]
9. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53. Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181 [TBL] [Abstract][Full Text] [Related]
10. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations. Ozçelik H; Mousses S; Andrulis IL Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Sheikh MS; Li XS; Chen JC; Shao ZM; Ordonez JV; Fontana JA Oncogene; 1994 Dec; 9(12):3407-15. PubMed ID: 7970699 [TBL] [Abstract][Full Text] [Related]
12. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333 [TBL] [Abstract][Full Text] [Related]
13. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702 [TBL] [Abstract][Full Text] [Related]
14. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations. Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790 [TBL] [Abstract][Full Text] [Related]
16. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Sourvinos G; Spandidos DA Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786 [TBL] [Abstract][Full Text] [Related]
17. p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Jiang M; Shao ZM; Wu J; Lu JS; Yu LM; Yuan JD; Han QX; Shen ZZ; Fontana JA Int J Cancer; 1997 Oct; 74(5):529-34. PubMed ID: 9355976 [TBL] [Abstract][Full Text] [Related]
18. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1. Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602 [TBL] [Abstract][Full Text] [Related]
19. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366 [TBL] [Abstract][Full Text] [Related]